Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream

Int J Dermatol. 2009 Feb;48(2):214-5. doi: 10.1111/j.1365-4632.2009.03576.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Aminoquinolines / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Basal Cell / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Imiquimod
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Middle Aged
  • Nose Neoplasms / drug therapy
  • Recombinant Proteins
  • Skin Neoplasms / drug therapy*

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Imiquimod